Document Detail

Use of glucocorticoids in pregnancy.
MedLine Citation:
PMID:  20977425     Owner:  NLM     Status:  In-Data-Review    
For many years glucocorticoids have been used world-wide in pregnant women for treatment of a variety of medical disorders, from bronchial asthma to systemic lupus erythematosous, to renal transplant. More recently their administration has been successfully addressed to the prevention of congenital fetal diseases. In some of these, such as for instance the 21-hydroxylase deficiency leading to congenital adrenal hyperplasia, the pathogenic mechanism is well known, while in others, such as the cystic adenomatoid malformation of the lung, it is not yet understood. Besides these types of diseases, there are acquired inflammatory conditions impairing the physiologic evolution of pregnancy that benefit from glucocorticoid administration. This is the case in recurrent miscarriage due to increased concentration of decidual Natural Killer cells, as well as in the Romero's syndrome, leading to premature parturition and related life threatening fetal complications. However, in spite of its prominent efficacy, the therapy is generally viewed with some suspicion because of possible fetal and maternal adverse effects. With the aim to contribute to a better knowledge of the basic mechanisms of glucocorticoid protection, we reviewed the regulation of their trans-placental passage, their biological effects on gestational environment, their possible 'programming' and teratogenic action, and their accepted use for prevention and cure of pregnancy complications. We believe that a more qualified and liberal use of these compounds will lead in many cases to a significant improvement of fetal and maternal prognosis.
L Lunghi; B Pavan; C Biondi; R Paolillo; A Valerio; F Vesce; A Patella
Related Documents :
1624095 - Prostaglandins and teleost neurohypophyseal hormones induce premature parturition in th...
2866985 - Ultrasonographic identification and measurement of the human fetal adrenal gland in utero.
11153525 - Fetal hypothalamus-pituitary-adrenal axis on the road to parturition.
12383325 - Increased first-trimester nuchal translucency as a prenatal manifestation of salt-wasti...
10426615 - Twin mothers, pregnancy hypertension and pre-eclampsia.
8498935 - Induction of labour in pregnancy complicated by cardiac disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current pharmaceutical design     Volume:  16     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2010  
Date Detail:
Created Date:  2011-01-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  3616-37     Citation Subset:  IM    
Department of Biochemical Sciences and Advanced Therapy, section of Obstetrics and Gynecology, University of Ferrara, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pro-inflammatory cytokines in animal and human gestation.
Next Document:  PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via ...